Item 8.01 Other Events.

On March 11, 2024, SELLAS Life Sciences Group, Inc. (the "Company") received a letter from The Nasdaq Stock Market ("Nasdaq") stating that the Company has regained compliance under Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement") by maintaining a minimum closing bid price of the Company's common stock of $1.00 per share for the last 10 consecutive business days, from February 26, 2024 to March 8, 2024, and that this matter is now closed.

As previously disclosed, on February 14, 2024, the Company received a letter from Nasdaq indicating that the Company was not in compliance with the Minimum Bid Price Requirement because, for a period of 30 consecutive business days, the closing bid price had not maintained a minimum of $1.00 per share. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided a grace period of 180 calendar days, or until August 12, 2024, to regain compliance with the Minimum Bid Price Requirement.

Attachments

  • Original Link
  • Permalink

Disclaimer

Sellas Life Sciences Group Inc. published this content on 11 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 March 2024 20:08:47 UTC.